PortalPublikationenS2k-Leitlinie Neuroendokrine Tumore

S2k-Leitlinie Neuroendokrine Tumore

Standard

S2k-Leitlinie Neuroendokrine Tumore. / Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).

in: Z GASTROENTEROL, Jahrgang 56, Nr. 6, 06.2018, S. 583-681.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung

Harvard

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) 2018, 'S2k-Leitlinie Neuroendokrine Tumore', Z GASTROENTEROL, Jg. 56, Nr. 6, S. 583-681. https://doi.org/10.1055/a-0604-2924

APA

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (2018). S2k-Leitlinie Neuroendokrine Tumore. Z GASTROENTEROL, 56(6), 583-681. https://doi.org/10.1055/a-0604-2924

Vancouver

Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). S2k-Leitlinie Neuroendokrine Tumore. Z GASTROENTEROL. 2018 Jun;56(6):583-681. https://doi.org/10.1055/a-0604-2924

Bibtex

@article{fc44fc7b4a664ed8840723b3e314b7b0,
title = "S2k-Leitlinie Neuroendokrine Tumore",
abstract = "This guideline was created for the first time and is intended as a practical aid for the diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients. The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies.",
keywords = "English Abstract, Journal Article",
author = "J{\"o}rg Schrader and {Deutsche Gesellschaft f{\"u}r Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)}",
note = "Leitlinie",
year = "2018",
month = jun,
doi = "10.1055/a-0604-2924",
language = "Deutsch",
volume = "56",
pages = "583--681",
journal = "Z GASTROENTEROL",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "6",

}

RIS

TY - JOUR

T1 - S2k-Leitlinie Neuroendokrine Tumore

AU - Schrader, Jörg

AU - Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

N1 - Leitlinie

PY - 2018/6

Y1 - 2018/6

N2 - This guideline was created for the first time and is intended as a practical aid for the diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients. The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies.

AB - This guideline was created for the first time and is intended as a practical aid for the diagnosis and therapy of neuroendocrine tumors. The aim is to represent the current state of science, promote the recognition of the disease and improve the treatment of patients. The guideline was created under the leadership of the DGVS and with participation of neighbouring scientific societies.

KW - English Abstract

KW - Journal Article

U2 - 10.1055/a-0604-2924

DO - 10.1055/a-0604-2924

M3 - Andere (Vorworte u.ä.)

C2 - 29890561

VL - 56

SP - 583

EP - 681

JO - Z GASTROENTEROL

JF - Z GASTROENTEROL

SN - 0044-2771

IS - 6

ER -